BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9600908)

  • 1. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein.
    Eberl H; Glockshuber R
    Biophys Chem; 2002 May; 96(2-3):293-303. PubMed ID: 12034448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
    Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic intermediate in the folding of human prion protein.
    Apetri AC; Surewicz WK
    J Biol Chem; 2002 Nov; 277(47):44589-92. PubMed ID: 12356762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations.
    Kuznetsov IB; Rackovsky S
    Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the PrP gene in transmissible spongiform encephalopathies.
    Weissmann C; Büeler H; Fischer M; Aguet M
    Intervirology; 1993; 35(1-4):164-75. PubMed ID: 8407244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR.
    Sharman GJ; Kenward N; Williams HE; Landon M; Mayer RJ; Searle MS
    Fold Des; 1998; 3(5):313-20. PubMed ID: 9806936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmissible spongiform encephalopathies.
    Liemann S; Glockshuber R
    Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.